1. Introduction {#sec1}
===============

Endometriosis, defined as the growth of endometrial tissue outside the uterine cavity, is a common gynecological disease often resulting in chronic pelvic pain and infertility. The pathogenesis of endometriosis is likely multifactorial and several hypotheses have been suggested to explain the presence of ectopic endometrial tissue and stroma, such as retrograde menstrual reflux \[[@B1]\], immune system defects \[[@B2]--[@B10]\], and ectopic presence of endometrial stem cells originating the disease \[[@B11]\]. In addition, there is a growing body of evidence indicating the involvement of genetic factors in the etiology of endometriosis, as it has been calculated that there is a 6--9-fold increased prevalence of this pathology among the 1st-degree relatives of women with endometriosis, compared to the general population \[[@B12]--[@B18]\]. Extensive investigations have been performed to characterize the differences between the eutopic and ectopic endometrium in order to better understand and define the molecular basis of the disease and, indeed, several studies have revealed a distinct pattern of gene expression in eutopic and ectopic endometrium \[[@B19]--[@B24]\]. The differences in gene expression reported in these works include genes encoding proteins involved in cell adhesion, extracellular matrix remodeling, migration, proliferation, immune system regulation, and inflammatory pathways, thus accounting for the multiple mechanisms hypothesized to be responsible for the establishment of ectopic endometrial implants, including the adhesion of endometrial cells to the pelvic peritoneum, invasion into the mesothelium, and survival and proliferation of the ectopic endometrial cells.

MicroRNAs (miRNAs), members of a class of small non-coding RNA molecules, have a critical role in posttranscriptional regulation of gene expression by repression of target mRNAs translation. Originally identified in *Caenorhabditis elegans*\[[@B25]\], miRNAs have been shown to operate in a wide range of species, including humans. Computational predictions indicate that up to 30% of human genes are potential targets of miRNAs and that miRNAs compose 1%--5% of animal genomes \[[@B26]--[@B29]\]. MiRNA expression is tissue- and cell-specific \[[@B30]--[@B32b]\]. It has been demonstrated that miRNAs are important in developmental processes as well as for other cellular activities involving cell growth, differentiation, and apoptosis. Moreover, several genes encoding miRNAs have been located at chromosomal fragile sites or regions of cytogenetic abnormalities associated with cancer and other disorders. Interestingly, miRNAs altered expression has been associated with tumorigenesis, and several studies have described differential expression of miRNAs in neoplastic *versus* normal tissue \[[@B33]--[@B37]\].

Our study is aimed to investigate the differential expression of miRNAs in endometriosis by direct comparison between paired ectopic and eutopic endometrium samples. Once we identified the differentially expressed miRNAs, we validated 5 of them by an independent technique. Then, we identified *in silico* the predicted molecular targets of the differentially expressed miRNAs and we used a bioinformatics tool to investigate the molecular pathways in which these targets could be involved.

2. Materials and Methods {#sec2}
========================

2.1. Tissue Collection {#sec2.1}
----------------------

Subjects (*n* = 16) scheduled for surgery for chronic pelvic pain or infertility at the University of Piemonte Orientale-affiliated "Maggiore della Carità" Hospital were recruited to participate in this study. The study was approved by the "Maggiore della Carità" Hospital\'s Institutional Review Board and informed consent was obtained from all participants. None of the authors have any conflict of interest with the study. Surgery was scheduled 6 to 12 days after the onset of menses. No patients were receiving hormone therapy at the time of the study or in the previous three months. The patients ranged in age from 24 to 48 years, with an average of 36 years. Endometriomas were removed at laparoscopy by excision of the entire cyst wall by stripping technique, preserving normal ovarian tissue. Hysteroscopy with directed biopsies, performed to obtain a sample of eutopic endometrium from the same patient, were carried out using a 4 mm Bettocchi Hysteroscope System with a 5 Fr operative channel (Karl Stortz GmbH & Co., Tuttlingen, Germany). Laparoscopy and hysteroscopy procedures were performed during the same surgical intervention. Freshly recovered tissues were rinsed in saline solution and divided in two parts. One half of the tissue was immediately snap-frozen and kept in liquid nitrogen for further processing, while the other was sent to the pathology laboratory. The endometriomas of 9 patients were classified as moderate, while 7 were classified as severe according to the ASRM guidelines \[[@B38]\].

2.2. RNA Isolation {#sec2.2}
------------------

Total RNA was extracted from tissues with the miRNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer\'s protocol and quantified by Quant-iT RNA Assay Kit with Qubit Fluorometer (Invitrogen, Carlsbad, CA, USA).

2.3. MicroRNA Microarray Assay and Analysis {#sec2.3}
-------------------------------------------

Microarray assay was performed using a service provider (LC Sciences). Ten *μ*g of total RNA from eutopic and ectopic endometrium obtained from three patients were size fractionated using a YM-100 Microcon centrifugal filter (Millipore) and the small RNAs (\<300 nt) isolated were 3′-extended with a poly(A) tail using poly(A) polymerase. An oligonucleotide tag was then ligated to the poly(A) tail for later fluorescent dye staining; two different tags were used for the two RNA samples in dual-sample experiments. Hybridization was performed overnight on a *μ*Paraflo microfluidic chip using a microcirculation pump (Atactic Technologies) \[[@B39], [@B40]\]. On the microfluidic chip, each detection probe consisted of a chemically modified nucleotide coding segment complementary to target 475 mature human miRNA probes (Sanger miRBase sequence database 9.1) or other RNAs for control and a spacer segment of polyethylene glycol to extend the coding segment away from the substrate. The detection probes were made by in situ synthesis using PGR (photogenerated reagent) chemistry. The hybridization melting temperatures were balanced by chemical modifications of the detection probes. Hybridization used 100 *μ*L 6xSSPE buffer (0.90 M NaCl, 60 mM Na~2~HPO~4~, 6 mM EDTA, pH 6.8) containing 25% formamide at 34°C. After RNA hybridization, tag-conjugating Cy3 and Cy5 dyes were circulated through the microfluidic chip for dye staining. Fluorescence images were collected using a laser scanner (GenePix 4000B, Molecular Device) and digitized using Array-Pro image analysis software (Media Cybernetics). Data from miRNA microarray were analyzed by the service provider first subtracting the background and then normalizing the signals using an LOWESS filter (Locally weighted Regression) \[[@B41]\]. The ratio of the two sets of detected signals (log2 transformed, balanced) and *P*-values of the *t*-test were calculated; differentially detected signals were those with less than  .01 *P*-values. Multiple sample analysis involved normalization, data adjustment, *t*-test, and clustering. Normalization was carried out using a cyclic LOWESS. Data adjustment included data filtering, Log2 transformation, and normalization. The *t*-test was performed between "control" and "test" sample groups \[[@B42]\]. *T*-values were calculated for each miRNA, and *P*-values were computed from the theoretical *t*-distribution. miRNAs with *P*-values \<.01 were selected for cluster analysis. The clustering was done using hierarchical method and was performed with average linkage and Euclidean distance metric \[[@B43]\] using TIGR MultiExperiment Viewer (<http://www.tm4.org/mev.html>).

2.4. Reverse Transcription and Real-Time PCR {#sec2.4}
--------------------------------------------

Real-time reverse transcription-polymerase chain reaction (real-time RT-PCR) was performed to confirm the differential expression of selected miRNAs, identified as differentially expressed by miRNA microarray, in paired samples from other 13 patients. TaqMan MicroRNA RT Kit (Applied Biosystems, Foster City, CA) was used for reverse transcription. Real-time RT-PCR reactions were carried out with a 7300 Real-Time PCR System (Applied Biosystems) according to the protocol provided by the supplier, using the TaqMan Universal PCR Master Mix No AmpErase UNG and the following TaqMan MicroRNA Assays: hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, hsa-miR-182, hsa-miR-202, and U18 as endogenous control.

Data from real-time RT-PCR experiments are presented as the mean ± SEM. The variation among groups was compared by means of nonparametric Wilcoxon and Mann-Whitney *U* tests. Statistical significance was assumed for *P*-values \<.05. Statistical analysis was performed with SPSS for Windows version 15.0 (SPSS; Chicago, IL).

3. Results and Discussion {#sec3}
=========================

3.1. MicroRNAs Differentially Expressed in Eutopic and Ectopic Endometrial Tissue {#sec3.1}
---------------------------------------------------------------------------------

In the present study, we used miRNA microarray technology to identify the pattern of miRNAs in paired eutopic/ectopic endometrium from the same patients, thus avoiding the variables attributable to heterogeneous genetic background between individuals and the effects of estrogenic stimulation during different phases of the menstrual cycle. Moreover, we considered the whole endometrial and endometriotic tissues in order to preserve the contribution of all the components of the tissues, including vascular and immune system components and to avoid potential changes in gene and miRNA expression due to cell isolation and manipulation.

Microarray technology has allowed a global analysis of all miRNAs differentially expressed in ectopic *versus* eutopic endometrium. The initial analysis of miRNA expression in ectopic endometrium compared with eutopic endometrium of three patient samples generated a list of 84 miRNAs significantly differentially expressed (*P*-values \<.01). The 50 miRNAs for which the expression value in ectopic endometrium was at least twofold higher or lower than in eutopic endometrium are listed in [Table 1](#tab1){ref-type="table"}.

3.2. Real Time RT-PCR Analysis of miRNA Expression {#sec3.2}
--------------------------------------------------

In order to confirm the results obtained with miRNA microarray, the expression analyses of 5 selected miRNAs was carried out by real-time RT-PCR on specimens from other 13 patients. These 5 miRNAs, namely, hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, hsa-miR-182, and hsa-miR-202, were selected because their expression resulted to be highly altered in ectopic endometrium compared with the matched eutopic tissue. We verified the differential expression of the selected miRNAs in the ectopic tissue by setting as 1 the expression of eutopic miRNAs. The results obtained by real-time RT-PCR are in accordance with those obtained from the microarray. Indeed, these miRNAs showed significant differential expression (*P*-values \<  .05) in eutopic *versus* ectopic tissue: hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, and hsa-miR-182 levels in ectopic endometrium were reduced up to 95% (Figures [1(a)](#fig1){ref-type="fig"}--[1(d)](#fig1){ref-type="fig"}), while hsa-miR-202 expression in ectopic endometrium was increased up to 60 folds compared to eutopic endometrium ([Figure 1(e)](#fig1){ref-type="fig"}). The analysis of data according to the severity of the endometrioma, by means of nonparametric Wilcoxon and Mann-Whitney *U* tests, failed to reveal any significant differences in miRNA expression levels, although this may be ascribable to the group size. Further studies increasing the cohort will be necessary to completely address this issue.

3.3. Identification of Predicted miRNA Targets and *In Silico* Functional Analysis {#sec3.3}
----------------------------------------------------------------------------------

The predicted target mRNAs of the differentially expressed miRNAs common to two different search algorithms, TARGETSCAN (<http://www.targetscan.org/>) and PICTAR-VERT (<http://pictar.mdc-berlin.de>), were 3093. The functions of these predicted targets and the molecular pathways in which they could be involved were assessed using Ingenuity Pathways Analysis software (Ingenuity IPA 7.5). The predicted targets were uploaded in IPA, and the software identified 49 significant molecular networks to which the predicted targets of the differentially expressed miRNAs belong ([Table 2](#tab2){ref-type="table"}). Among the biological functions reported to be statistically significant by IPA there were functions known to be involved in endometriosis such as gene expression, cellular growth and proliferation, cellular development, cellular movement, cell death, cell cycle, cancer, and reproductive system disorders. One of the subcategories of reproductive system disorders to be more represented, with *P*-value (calculated by Fisher\'s Exact test) of 6.1 · 10^−18^, was endometriosis with 119 molecules directly involved in this pathology ([Table 3](#tab3){ref-type="table"}).

An exemplificative network identified by IPA enriched for miRNA targets involved in endometriosis is shown in [Figure 2](#fig2){ref-type="fig"}. This network, converging on estrogen receptor 1 (ESR1), includes the DNA methyltransferases DNMT3A and DNMT3B that are validated targets of hsa-miR-29b and hsa-miR-29c, and of hsa-miR-29b, hsa-miR-29c, and hsa-miR-148a, respectively \[[@B44], [@B45]\]. DNA methylation is an epigenetic modification that is involved in gene silencing, chromatin remodeling, and genome stability \[[@B46]\]. It has been demonstrated that DNMT1, DNMT3A, and DNMT3B are disregulated in endometriosis \[[@B47]\], and it has been suggested that aberrant methylation of HOXA10 and of the progesterone receptor PR-B may be responsible of the disregulation of their expression in endometriosis. Thus, this network strongly suggests a possible involvement of miRNAs in these mechanisms.

To further analyze the possible role of these differentially expressed miRNAs in endometriosis, we performed a different analysis uploading the miRNAs directly in IPA. In this way, the software identified 6 networks, 3 of which are highly significant with known biological functions including genetic disorders, connective tissue disorders, skeletal and muscular disorders, cancer, and reproductive system disorders ([Table 4](#tab4){ref-type="table"}).

The difference in the number of networks identified by IPA is ascribable to the different database used by the software, as IPA uses the Argonaute 2 databases (<http://www.ma.uni-heidelberg.de/apps/zmf/argonaute/>) to analyse miRNAs and their known or predicted targets, and this database identified only 118 targets for the 50 miRNAs.

Next, we performed an IPA analysis on the 1203 predicted targets of the miRNAs whose differential expression between eutopic and ectopic tissue was confirmed by real-time RT-PCR. IPA software identified 49 networks and revealed that the predicted targets were enriched for biological functions such as cellular development, cell morphology, cell-mediated immune response, gene expression, cell cycle, cell death, cancer, and developmental disorders. The network with the highest score from this analysis, shown in [Figure 3](#fig3){ref-type="fig"}, includes molecules that have been implicated in endometriosis such as the TNF receptor, IL10, IL6, and FOXO1 \[[@B48]--[@B54]\].

Performing the analysis uploading directly the miRNAs in IPA, thus using the Argonaute2 database, the software identified only one network ([Figure 4](#fig4){ref-type="fig"}), the major biological functions of which are cell cycle, cell death, and connective tissue disorders. This network contains PIK3R1, and its expression has been demonstrated to be upregulated in endometriosis, were it can play an essential role in TNF-mediated antiapoptotic signaling \[[@B55]\]. Another interesting molecule present in this pathway is SIP1, a validated target of the miR-200 family, which is a factor implicated in epithelial to mesenchymal transition and tumor metastasis \[[@B56]\]. Thus, the observed downregulation of miR-200 family in the ectopic endometrium may have a role in the endometrial lesion development.

We further investigated the function of the predicted targets of the RT-PCR-validated miRNAs by using Onto-Express and Pathway-Express (<http://vortex.cs.wayne.edu/>) in order to categorize the targets according to Gene Ontology (GO) and KEGG pathways, respectively \[[@B57], [@B58]\]. The predicted targets of the validated miRNAs were uploaded in Onto-Express and the list of the putative targets of the 475 miRNAs assayed was used as reference. Onto-Express calculates the mRNA targets in each GO category and compares it with the expected number of targets present in the GO category. Significant differences from the expected number of genes were calculated assuming a hypergeometric distribution, and *P* values were adjusted with the false discovery rate correction based on the number of GO categories tested. A corrected *P* value \<.05 was considered statistically significant. Onto-Express analysis revealed enrichment for several biological processes known to be relevant in endometriosis, such as developmental process, cell death, cell cycle, and cell adhesion ([Table 5](#tab5){ref-type="table"}).

Pathway-Express analysis identified 33 pathways significant at 5% level ([Table 6](#tab6){ref-type="table"}), most of which are coherent with the current knowledge on endometriosis. For instance, the most significant pathways putatively affected by the differential expression of miRNAs are *MAPK* and *axon guidance* the latter shown in [Figure 5](#fig5){ref-type="fig"}. While *MAPK* pathway, which is involved in several cellular functions, such as cell proliferation, migration, and differentiation, is clearly relevant for endometriosis, *axon guidance*, at first may appear unrelated to this pathology. However, nerves and blood vessels are highly interconnected, both physically and in their morphogenesis. Indeed, it has been demonstrated that several molecules involved in axon guidance, such as semaphorins, plexins, and neuropilins, are also strongly implicated in angiogenesis \[[@B59]\], a biological process essential for endometriosis. Intriguingly, this pathway contains ROBO1, and its expression, higher in ectopic endometrium compared to eutopic tissue, positively correlates with endometriosis recurrence \[[@B60]\], thus suggesting that miRNAs may take part in tuning ROBO1 expression and have a role in the recurrence of the pathology.

3.4. Genes Differentially Expressed in Endometriosis Are Predicted Targets of the Differentially Expressed miRNAs {#sec3.4}
-----------------------------------------------------------------------------------------------------------------

Finally, after the identification of the predicted targets of the differentially expressed miRNAs, we investigated whether they were in accordance with the results of two studies of gene expression in endometriosis. We first analysed the genes reported to be differentially expressed in a study on paired eutopic and ectopic samples of ovarian endometriosis \[[@B23]\]. This study identified 701 differentially expressed transcripts (expression ≥ 0.2; fold change ± ≥ 2; *P* ≤ .05), 82 of which are predicted target genes of the 50 miRNAs, 51/492 upregulated and 31/209 downregulated. A second study on peritoneal endometriosis \[[@B24]\] identified 622 differentially expressed transcripts (fold change ± ≥ 1.5; *P* ≤ .05), 107 of which are predicted targets of the differentially expressed miRNAs, 73/232 upregulated and 34/390 downregulated. Hypothesising that the genes differentially expressed common to both studies are likely those specific to endometriosis independently from the site of the lesion, we restricted the analysis to the differentially regulated genes in eutopic and ectopic endometrium common to the two studies that are also predicted targets of the 50 miRNAs ([Table 7](#tab7){ref-type="table"}). IPA analysis identified 5 molecular networks, the most relevant functions of which being cancer, cell cycle, and reproductive system disease ([Table 8](#tab8){ref-type="table"}). The overlap of networks generated by IPA is shown in [Figure 6](#fig6){ref-type="fig"}. In this graphical representation the most relevant nodes are the transcription factor SP1, tumor necrosis factor (TNF), and SRC, in remarkable agreement with the nodes of the most significant networks obtained by IPA analysis performed on the distinct datasets of differentially expressed genes in ovarian and peritoneal endometriosis (data not shown).

4. Conclusions {#sec4}
==============

MicroRNAs are predicted to regulate a large fraction of protein-coding genes, as computational analysis reveals that an average miRNA could have as many as 100 or more target genes. On the other hand, a single gene may have target sites for several distinct miRNAs, allowing a fine tuning of gene expression by miRNAs.

In the present study, we used miRNA microarray technology to identify the miRNAs differentially expressed in paired eutopic/ectopic endometrium from the same patients and bioinformatics tools to identify their predicted targets as well as the molecular networks and the biological functions they may affect.

Comparing miRNA expression profiles among the different subjects, we identified 50 miRNAs differentially expressed in ectopic *versus* eutopic samples. Several of these miRNAs were also reported to be differentially expressed in two recent studies \[[@B61], [@B62]\], although with a modulation occasionally discordant from our results. This, joint to a notable accordance between their predicted targets and the genes reported to be differentially expressed in two studies of gene expression \[[@B23], [@B24]\], consolidates the hypothesis of a possible role of miRNAs in the pathogenesis of endometriosis.

The miRNAs-predicted targets were identified by the intersection of the results from two different search algorithms, and the biological functions the differentially expressed miRNA may affect were identified by Onto-Express and IPA software. Functional analysis, performed using IPA software, was carried out uploading either the predicted targets or the differentially expressed miRNAs, thus using different databases for miRNA targets. As expected, the different algorithms used to predict miRNA targets led to the identification of different molecular networks. Still, in both cases, the identified networks contained several transcripts known to be implicated in endometriosis and with their main biological functions linked to the disease. Since the targets of miRNAs are just predictions based on mathematical algorithms, the choice of the algorithm may radically modify on the whole the list of the predicted target genes and that of the molecular networks they belong to. For this reason, the validation of miRNA targets in vitro, in a cellular system, is essential to evaluate the contribution of each miRNA to the overall modulation of gene expression.
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![Differential expression of miRNAs in ectopic *versus* eutopic endometrium. The miRNAs selected for independent validation were among those with wider difference in expression between eutopic and ectopic endometrium. The differential expression of the selected miRNAs in the ectopic *versus* eutopic tissues was evaluated by real-time RT-PCR. The expression of each miRNA in eutopic tissue was set to 1. (a) hsa-miR-200a, (b) hsa-200b, (c) hsa-miR-200c, (d) hsa-miR-182, and (e) hsa-miR-202. \**P*  \<  .05.](JBB2010-369549.001){#fig1}

![Functional analysis of all the predicted targets of the differentially expressed miRNAs. Graphical representation of network \#2 obtained by IPA analysis. Genes are represented as nodes, and the biological relationship between two nodes is represented as a line. Every line is supported by at least one reference in literature. Highlighted, the genes involved in endometriosis according to IPA knowledge base.](JBB2010-369549.002){#fig2}

![Functional analysis of the predicted targets of miR-182, miR-200a, miR-200b, miR-200c, and miR-202 identified by Pictar and Targetscan: graphical representation of one of the network (*P*-value = 10E−37, focus molecules = 35) identified by IPA analysis of the predicted targets of the miRNAs whose differential expression in eutopic and ectopic endometrium was validated by real-time RT-PCR. Highlighted are the genes involved in endometriosis according to IPA knowledge base.](JBB2010-369549.003){#fig3}

![Functional analysis of the predicted targets of miR-182, miR-200a, miR-200b, miR-200c, and miR-202 identified by Argonaute2: graphical representation of the network identified by IPA analysis of the miRNAs and their predicted targets using the database generated by Argonaute2 algorithm (*P*-value = 10E−14, focus molecules = 4).](JBB2010-369549.004){#fig4}

![The axon guidance pathway identified by Pathway-Express analysis. Pathway-Express analysis performed on the predicted targets of the 50 differentially expressed miRNAs identified, among the most significant KEGG pathways predicted to be relevant for endometriosis, the *axon guidance* pathway. In yellow are the predicted targets of the differentially expressed miRNAs.](JBB2010-369549.005){#fig5}

![Functional analysis of the differentially regulated genes common in ovarian and peritoneal endometriosis that are predicted targets of the 50 miRNAs: Graphical representation of the overlap of the networks identified by IPA with, highlighted are the genes involved in endometriosis according to IPA knowledge base.](JBB2010-369549.006){#fig6}

###### 

Differentially expressed miRNAs in ectopic *versus* eutopic endometrium. List of differentially expressed miRNAs whose expression value in ectopic endometrium was at least twofold higher or lower than in eutopic endometrium *P* \< .01.

  Name             EU          EC          *P*-value
  ---------------- ----------- ----------- -----------
  hsa-miR-1        36.29       2,090.27    .00E+00
  hsa-miR-100      7,517.73    18,712.43   .00E+00
  hsa-miR-101      341.51      2,348.69    .00E+00
  hsa-miR-106a     3,264.74    1,510.10    1.11E−16
  hsa-miR-106b     2,996.55    1,414.14    .00E+00
  hsa-miR-126      10,373.88   22,435.79   .00E+00
  hsa-miR-130a     1,634.84    5,145.94    .00E+00
  hsa-miR-130b     673.04      249.86      .00E+00
  hsa-miR-132      3,699.14    1,261.33    .00E+00
  hsa-miR-143      8,104.26    21,764.97   .00E+00
  hsa-miR-145      10,992.36   27,550.33   .00E+00
  hsa-miR-148a     2,623.73    6,507.58    .00E+00
  hsa-miR-150      1,621.96    4,503.15    .00E+00
  hsa-miR-17-5p    4,517.66    2,059.32    .00E+00
  hsa-miR-182      1,998.92    230.69      .00E+00
  hsa-miR-183      410.83      41.02       .00E+00
  hsa-miR-186      56.69       246.79      1.21E−14
  hsa-miR-196b     380.45      14.13       .00E+00
  hsa-miR-199a     4,481.27    12,618.11   .00E+00
  hsa-miR-200a     582.95      33.22       .00E+00
  hsa-miR-200b     17,643.11   675.98      .00E+00
  hsa-miR-200c     25,249.55   1,391.63    .00E+00
  hsa-miR-202      49.64       471.06      2.27E−13
  hsa-miR-20a      5,278.72    2,534.21    9.05E−14
  hsa-miR-221      5,368.05    10,915.55   .00E+00
  hsa-miR-25       12,878.14   6,328.31    1.06E−14
  hsa-miR-28       1,465.55    4,589.04    .00E+00
  hsa-miR-299-5p   202.34      452.17      5.18E−13
  hsa-miR-29b      248.51      4,963.66    .00E+00
  hsa-miR-29c      295.40      10,562.63   .00E+00
  hsa-miR-30e-3p   299.19      1,003.48    1.50E−14
  hsa-miR-30e-5p   58.94       428.59      .00E+00
  hsa-miR-34a      337.65      861.73      .00E+00
  hsa-miR-365      264.57      2,071.70    .00E+00
  hsa-miR-368      297.52      1,882.43    .00E+00
  hsa-miR-375      1,329.85    13.62       .00E+00
  hsa-miR-376a     64.20       522.49      .00E+00
  hsa-miR-379      175.21      601.12      7.19E−13
  hsa-miR-411      62.72       215.67      5.92E−16
  hsa-miR-425-5p   961.30      329.99      .00E+00
  hsa-miR-486      2,824.50    956.89      .00E+00
  hsa-miR-493-5p   64.60       355.15      7.22E−12
  hsa-miR-503      2,084.95    465.94      .00E+00
  hsa-miR-638      29,531.60   11,202.65   .00E+00
  hsa-miR-663      4,654.42    1,943.14    4.44E−15
  hsa-miR-671      2,052.70    955.73      .00E+00
  hsa-miR-768-3p   5,841.89    2,901.78    2.81E−06
  hsa-miR-768-5p   5,321.54    2,456,43    .00E+00
  hsa-miR-93       2,614.63    629.20      .00E+00
  hsa-miR-99a      6,766.02    18,369.57   .00E+00

###### 

Molecular networks constituted by the predicted miRNA targets. IPA analysis was performed in order to identify the molecular pathways and functions to which the predicted targets of the differentially expressed miRNAs belong. The networks are generated on the basis of the published literature and ranked by the *P*-value calculated by Fisher\'s exact Test. The biological processes in which the targets are involved are determined by IPA using the GOstat application *P* \< .01.

  ID   Molecules in network                                                                                                                                                                                                                                                                                   *P*-value   Focus molecules   Top functions
  ---- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------- ----------------- ------------------------------------------------------------------------------------------------------------------------------------
  1    ACTR1A, ADM, APP, BICD2, CABP7, CELSR1, CPSF6, DAG1, ELAVL1, EPHA2, GCH1, GNA13, HIRA, HLX, HNRNPH1, HNRNPM, IFNG, IRF2, KHDRBS1, LARGE, MAPT, MTMR3, MTMR4, MYH9, PCSK2, PLCG1, PTGS2, RASA1, SBF1, SOCS1, SOCS2, STAT6, TNPO1, TNPO2, TRIB2                                                          10E−21      35                Cellular Development, Skeletal and Muscular Disorders, Organismal Development
                                                                                                                                                                                                                                                                                                                                            
  2    AEBP2, ATAD2, C1QTNF6, CAV1, CAV2, CBX1, CCND1, CREB1, DAB2IP, DDIT4, DNMT1, DNMT3A, DNMT3B, DUSP9, EED, ESR1, EZH2, FOLR1, HSPA13, KAT2B, LEP, MED1, MED14, NCOA2, NCOA3, NCOA4, NOTCH3, PHF1, PNRC1, PRLR, RBBP7, RBM9, SIRT1, THRA (includes EG:7067), TMOD1                                        10E−21      35                Gene Expression, Cellular Growth and Proliferation, Developmental Disorder
                                                                                                                                                                                                                                                                                                                                            
  3    AKAP13, BCL2L11, CCNE2, CDK6, CDKN1A, CDKN1B, CTGF, CTSB, CUGBP1, DUSP1, E2F1, ESRRG, ETS1, FHL2, FLI1, FOXO1, FOXO3, FOXO4, IGFBP3, IP6K3, JAG1, KRAS, MCF2, NR3C1, PRKD3, RB1CC1, SGK1, SMAD3, SP1, SPHK2, TCF7L2 (includes EG:6934), TGFBR1, TIMP3, TOPBP1, TSPYL2                                  10E−21      35                Cellular Growth and Proliferation, Cellular Development, Cancer
                                                                                                                                                                                                                                                                                                                                            
  4    ADAM12, BCL2, CITED2, EGLN1, FGF9, FRAP1, GATA3, GNAI2, HIF1A, HSPD1, IGF1R, IKBKB, ITGA9, JUNB, KPNA1, KPNB1, MAP2K3, MAP2K5, MAP3K7, MAP3K7IP2, PIAS3, PPM1B, PRKCE, PTEN, PTPN1, RPS6KB1, SKI, SMAD7, SNAI1, SOCS3, SP2, STAT3, UBR5, WT1, ZEB1                                                     10E−21      35                Cellular Growth and Proliferation, Cellular Movement, Cell Cycle
                                                                                                                                                                                                                                                                                                                                            
  5    ANP32A, ATP2A2, CD69, CDK5R1, COL1A1, COL1A2, CREM, DDR1, DLL4, E2F3, EGR1, FBXW7, FLT1, HDAC4, IL2, IL18BP, LPL, NDRG1, NOTCH1, PHC1, PHC2, POLA1, PPARA, RANBP2, RB1, RYBP, SHC1, SP3, SP4, TRAM2 (includes EG:9697), XPO1, YBX1, YY1, ZBTB10, ZBTB7B                                                10E−21      35                Organismal Injury and Abnormalities, Cardiovascular Disease, Cellular Development
                                                                                                                                                                                                                                                                                                                                            
  6    ARNT, BACH1, BCL2L12, BRCA1, CLOCK, CREBBP, CYP1B1, DDX5, EP300, EPAS1, ERBB4, EREG, GABPA, GADD45A, HBEGF, HOXA13, HOXB6, LEF1, MAB21L1, MAX, NCAM1, NFYA, NPAS2, OXTR, PIN1, PPARG, PPP2CA, PTGER4, RBBP8 (includes EG:5932), RUNX1, SDC1, SLC1A2, TGFA, TRERF1, WNT5A                               10E−21      35                Gene Expression, Cancer, Genetic Disorder
                                                                                                                                                                                                                                                                                                                                            
  7    ACTB, ARID1A, ARID1B, ARID4A, ARID4B, BTG2, CLIP1, DR1, ETS2, EWSR1, GTF2B, HOXA9, PFN1, RARB, RBL1, RBL2, SAP30, SAP130, SFPQ, SIN3A, SMARCA2, SMARCA4, SMARCB1, SMARCC1, SMARCC2 (includes EG:6601), SNIP1, SUMO1, TACC2, TAF4, TAF5, TAF12, TBP, TDG, TOP1, XPO6                                    10E−21      35                Gene Expression, Cellular Assembly and Organization, Cellular Compromise
                                                                                                                                                                                                                                                                                                                                            
  8    ARHGDIA, BTRC, CASP3, CD4, CDC42, CLTC, CTTN, CXCL12, DIABLO, ELK1, ELK3, EZR, F3, FOS, FOSB, GLI3, GSK3B, HNRNPA1, HNRNPC, IL1A, ITPR1, JUND, MAP1B, MCL1, OCRL, PAK1, PGM1, PRKCI, PRKD1, PTX3, RABEP1, RAC1, SEMA3A, SRF, STK4                                                                      10E−21      35                Cell Death, Cancer, Cellular Assembly and Organization
                                                                                                                                                                                                                                                                                                                                            
  9    CD47, CSF1, CSF1R, CSK, EPHA4, FASLG, FGF1, FN1, FOXP1, GRB2, IRS2, ITGA5, ITGA6, ITGA10, ITGA11, ITGAV, ITGB1, ITGB3, JAK2, KCNA3, MAP2K1, MAP2K4, MAPK1, MET, MITF, NFAT5, PDGFB, PDGFRB, PLXNB1, RAB21, SERPINE1, TNFRSF1A, TNFSF11, TRIB1, YES1                                                    10E−21      35                Cellular Growth and Proliferation, Cell-mediated Immune Response, Cellular Movement
                                                                                                                                                                                                                                                                                                                                            
  10   ACTR3, AR, ARHGEF7, ASAP1, CRKL, DYRK1A, ESR1, GDI1, KLF2, LMOD1, LRRK1, MRAS, NCK1, PFTK1, PLS3, POMT2, TEAD3, TRIP10, WAS, WEE1, WIPF1, ZMIZ1                                                                                                                                                        10E−9       19                Cellular Assembly and Organization, Skeletal and Muscular System Development and Function, Cancer
                                                                                                                                                                                                                                                                                                                                            
  11   AKAP12, AMOTL2, ARL6IP1, ATM, BRCA1, CDC6, CHEK2, E2F1, FKBP3, HS3ST1, LATS2, LBR, MBNL2, MTDH, PPM1D, PPP1R13B, SCN3B, SH3BP4, TP53, TRIO, VCAN                                                                                                                                                       10E−7       17                Cancer, Genetic Disorder, Reproductive System Disease
                                                                                                                                                                                                                                                                                                                                            
  12   ANK3, CREB5, DEDD, FRK, GPRC5A, KCNK2, KRT18, MPZL2, MYCBP2, MYO1B, NRK, RAB22A, SPAG9, ZNF217                                                                                                                                                                                                         10E−7       13                Cardiovascular Disease, Cellular Development, Cell Morphology
                                                                                                                                                                                                                                                                                                                                            
  13   ADAM19, CADM1, CBFA2T3, CDC42SE1, COL6A3, COL7A1, DAAM1, ERBB2, FN1, HAS3, MFAP2, MPHOSPH9, NET1, PMEPA1, RAP1B, TGFB1, THBS1, THPO, XYLT1, ZFP36                                                                                                                                                      10E−7       16                Cancer, Cellular Growth and Proliferation, Dermatological Diseases and Conditions
                                                                                                                                                                                                                                                                                                                                            
  14   ATP1B3, CCND1, COL3A1, COL4A1, COL5A2, CTNNB1, HOXA1, IGF2R, KLF9, LGALS3, M6PR, MAP3K10, NANOG, NPTX1, NRF1, NRIP1, PTPRC, PTTG1, RB1, SPTBN2, TCF7L2 (includes EG:6934), THRB (includes EG:7068), TP53                                                                                               10E−6       17                Organismal Development, Cancer, Cell Cycle
                                                                                                                                                                                                                                                                                                                                            
  15   ALDH1A3, COLQ, DUSP10, EIF4B, GPD2, HSPE1, IL6, IL13, IL1B, MMD, NR4A3, NUAK1, PTPN12, RND3, ROBO1, SEMA3C, SLC7A1, STAC, TNF, TNFSF10, TUB                                                                                                                                                            10E−6       16                Small Molecule Biochemistry, Skeletal and Muscular System Development and Function, Cell-To-Cell Signaling and Interaction
                                                                                                                                                                                                                                                                                                                                            
  16   ACSL3, ASXL1, EGR3, JMJD1C, PLK2, PTP4A1, RRM2, RRM1 (includes EG:6240), RRM2B, SEL1L, SFRS3, SLC2A1, SMURF2, SON, STRN3, TNF, TP53, UBE2B, ZFP36L1                                                                                                                                                    10E−6       15                Nucleic Acid Metabolism, Small Molecule Biochemistry, Genetic Disorder
                                                                                                                                                                                                                                                                                                                                            
  17   CCND1, CCNT1, CCNT2, CDK9, CDKN1A, DNAJB9, FBXW11, GLI1, GLI2, GNAO1, GTF2F2, HSPA5, HTATSF1, ID2, JAG2, MDFIC, MXI1, MYCN, NPM1 (includes EG:4869), POLR2A, POLR2C, RB1, RPS6KA1, RXRA, SFRS1, SUPT5H, SUPT6H, TCERG1, TGFB1, TP53, ULK1                                                              10E−6       20                Gene Expression, Cellular Development, Cell Cycle
                                                                                                                                                                                                                                                                                                                                            
  18   APBB2, BECN1, CAD, CDKN1A, CFL1, E2F5, ESR1, FANCA, FANCC, FGF7, GFI1, GJA1, GORASP2, HSP90AA1, LIMK1, MAX, MYC, PCBP2, PERP, PTBP1, SPTAN1, TERT, TMSB4X, TP53, XBP1                                                                                                                                  10E−5       17                Cell Cycle, Connective Tissue Development and Function, Cellular Compromise
                                                                                                                                                                                                                                                                                                                                            
  19   AP3M1, BCL6, CCND1, CREBL2, ENC1, FOXA1, FTH1, HNF1A, HNMT, MTA3, MUC4, NCOR1, NCOR2, NFE2L2, NFYC, NR5A2, SNX17, SSTR1, TFR2, TFRC, TMOD2                                                                                                                                                             10E−5       15                Cancer, Gene Expression, Drug Metabolism
                                                                                                                                                                                                                                                                                                                                            
  20   ACTB, ACTL6A, CCNT1, CD9, CTCF, DMAP1, EMD, EPC1, ESR1, HABP2, HNRNPA1, HNRNPF, HNRNPK, HSP90AA1, LEMD3, MKNK2, MORF4L1, MYC, PCBP1 (includes EG:5093), SYNE2, TBP, THOC4, TNPO1, TRRAP, U2AF1, WNT1, WNT2B, YY1, ZBTB33                                                                               10E−5       18                Gene Expression, Cancer, Reproductive System Disease
                                                                                                                                                                                                                                                                                                                                            
  21   BEX2, CDH1, CDH2, CDH11, CTNNA2, CTNNB1, CTNND2, DIO2, ELAVL1, EPHB3, ERBB2, ESR1, F13A1, HNRNPD, ILF3, IRS1, JUP, KHSRP, LDB1, LMO2, NHLH2, PIK3R1, PKD1, PPP3CA, PTCH1, PTPRF, TCF7L2 (includes EG:6934), TIAL1, TP53, TSC22D1, ZNF346                                                               10E−4       18                Cell-To-Cell Signaling and Interaction, Cancer, Cellular Growth and Proliferation
                                                                                                                                                                                                                                                                                                                                            
  22   ACIN1, AP2A1, BRD2, COIL, EIF4A1, EIF4G3, ICMT, LMO7, MAP7, NME1, PA2G4, PABPC1, PABPN1, PAIP1, PAIP2, PAPOLG, PNN, RNGTT, RNPS1, SAP18, SFRS11, TALDO1, TRA2B, ZNF143                                                                                                                                 10E−4       15                RNA Post-Transcriptional Modification, Protein Synthesis, Gene Expression
                                                                                                                                                                                                                                                                                                                                            
  23   ADAM9, ADAM10, BMP7, CCL2, CCL5, CDH1, COL18A1, CTNNB1, DICER1, EGF, EGFR, EPS15, ERBB2, ETV1, GRB2, HGS, IL8, L1CAM, LPAR1, LPP (includes EG:4026), MAP3K14, NKRF, RALA, RELA (includes EG:5970), SHC1, SMAD5, SPG20, SRC, TBK1, TERT, TJP1, TMEM55A, TMEM55B, TNF                                    10E−4       19                Cell-To-Cell Signaling and Interaction, Tissue Development, Cancer
                                                                                                                                                                                                                                                                                                                                            
  24   ALOX15, BZW2, CCL3, CHST2, DHCR24, FCER2, GAS7, GATA6, IGHE, IL4, IL8, IL13, MTSS1, NHLH1, NOS2, NOTCH2, PDGFC, PHLDA1, PLXNC1, RIN2, SORT1, ST8SIA4                                                                                                                                                   10E−4       14                Genetic Disorder, Inflammatory Disease, Respiratory Disease
                                                                                                                                                                                                                                                                                                                                            
  25   CAND1, CCND2, CDC5L, CDKN1B, CUL1, CUL2, CUL3, DNTT, FBXL3, FBXW2, GPR37, PARK2, PITX2, PLRG1, PMS1, PRCC, PRPF19, PSMA2, PSMC1, PSMC5, RAD23B, RBX1 (includes EG:9978), SFRS2, SKP1, SKP2, TCEB1, VHL                                                                                                 10E−4       16                Post-Translational Modification, Cancer, Immunological Disease
                                                                                                                                                                                                                                                                                                                                            
  26   AMOT, B4GALT5, BTG3, CCL2, CD40, CHMP2B, CLASP1, ETS1, F3, FOS, HIVEP1, IKBKB, IL2, IL6, IL15, JAK1, JUN, MAPK1, MAPK14, MVP, NEFM, NFKB1, NFKBIA, PLG, PPP2R1B, RAB32, RELA (includes EG:5970), RFWD2 (includes EG:64326), RGS2, SQSTM1, STAT1, STAT3, TNF, TYK2, ZBTB11                              10E−4       19                Hematological System Development and Function, Cell Death, Cell Cycle
                                                                                                                                                                                                                                                                                                                                            
  27   CCNA2, CCNB1, CCNE1, CCNE2, CD46, CD59, CDK2, CDKN1C, E2F4, EPHB2, FBXO32, HDAC9, HIVEP2, IGFBP3, KLF4, LATS1, LTC4S, MYB (includes EG:4602), MYBL2, NDC80, NUMB, PCNA, PLAU, POLD1, RALBP1, RBL1, RBL2, RFC4, RFX1, SCD, SPARC, SUZ12, TGFB1, TGFB3, TNS3                                             10E−4       19                Cell Cycle, Cancer, Cellular Growth and Proliferation
                                                                                                                                                                                                                                                                                                                                            
  28   ABL1, ADRB2, ATP1A1, ATP1A2, ATP1B1, BCAR1, BCAR3, BCR, CBL, CRK, DOCK1, FRAP1, FYN, GATA2, GRK4, ITGA2B (includes EG:3674), ITGB3, MAPK9, MGRN1, NEU2, PIAS1, PIK3R1, PLSCR1, PRKCD, PTK2, RAPGEF1, RECK, SP3, SRC, STAT1, TIMP2, TP73, TP53INP1, TSG101, VPS28                                       10E−4       19                Cell Death, Cellular Movement, Cellular Growth and Proliferation
                                                                                                                                                                                                                                                                                                                                            
  29   AKAP11, B2M, BHLHE40, CALD1, CEBPA, CHI3L1, COL16A1, EDN1, EDNRB, EIF1AX, EMP1, HMGA1, HMGCR, HMGCS1, IDI1, INSIG1, IPO13, KIT, KITLG, LSS, MMP2, MMP3, NAMPT, NPPB, PRKCA, PTPN6, RETN, SCARB1, SERPINB1, SERPINE1, TGFBR2, TGIF2, TNC, TNF, UBE2I                                                    10E−4       19                Cancer, Hematological Disease, Lipid Metabolism
                                                                                                                                                                                                                                                                                                                                            
  30   ALOX12B, APOE, ATF7IP, BCAT2, CAMK2A, CAMK2N1, CCND3, CDKN1B, CHAF1A, CRYBB2, DPP4, EFNA5, ESR1, GSTP1, HBE1, IL4, IL13RA1, IRF4, KCNK10, MBD1, MBD2, MBD3 (includes EG:53615), MECP2, MGMT, NR1H3, NR2F2, PIP5K3, PRLR, PTPN4, PTPRM, SETDB1, SLCO3A1, TFF2, TP53BP2, TSC1                            10E−4       19                Behavior, Reproductive System Development and Function, Neurological Disease
                                                                                                                                                                                                                                                                                                                                            
  31   ARHGEF6, BNIP2, CASP8, CHFR, CPD, CS, ELF1, IFNB1, IL8, IL16, INS, IRF1, JAK2, LMTK2, NCF2, NFKBIA, NGFR, PGAM1, PGK1, PLAGL2, PPP1CC, PPP1R12B, PRL, STAT1, TNF, TRADD                                                                                                                                10E−3       15                Immunological Disease, Cell Death, Hematological Disease
                                                                                                                                                                                                                                                                                                                                            
  32   ACHE, AGT, APP, ATP2B1, BACE1, BIK, BMP2, BTG2, CCL20, CD40LG, CDH1, CXCL2, CYCS (includes EG:54205), EFNA1, EIF4E, EIF4EBP1, GCLC, ITM2B, JUN, LAMP3, LYN, MYO6, PDK4, PPARD, PSEN1, PTGS2, PXN, SMAD1, SMPD2, SOX9, TNF, TNFAIP2, TNFSF10, TRPV6, VCL                                                10E−3       18                Cell Death, Cancer, Cell-To-Cell Signaling and Interaction
                                                                                                                                                                                                                                                                                                                                            
  33   AHR, ANP32B, ATM, BIRC3, BTG2, CAMK2G, CEBPE, CLU, ELAVL1, ERCC1, GDF11, H2AFX, HDAC3, HNRNPD, HNRNPU, HOXA5, ILF3, NEDD8, NUP153, RAD50, RARA, RARB, RARG, TBX3, TERF2, TERF2IP, TIA1, TIAL1, TINF2, TP53, TPR, XPO1, XRCC5, XRCC6, YAP1                                                              10E−3       18                Cell Cycle, DNA Replication, Recombination, and Repair, Cell Death
                                                                                                                                                                                                                                                                                                                                            
  34   ADH5 (includes EG:128), ASH2L, ATP6V0C, C16ORF53, CHRNA5, CSNK2A1, CSNK2B, DPY30, EDA, ETV4, HCFC1, HDAC1, HIST2H4A, MIER1, MLL3, MLL4, MRC2, NCOA6, OGT (includes EG:8473), PAXIP1, PKNOX1, PLAU, PLAUR, POU2F1, RBBP5, SIN3A, SP1, SP3, SSRP1, SUB1, SUPT16H, TEAD1, TRIM63, WDR5, ZBTB7A            10E−3       18                Gene Expression, Cell Morphology, Reproductive System Development and Function
                                                                                                                                                                                                                                                                                                                                            
  35   APLN, BID, CASP2, CFLAR, CXCL13, CYCS (includes EG:54205), DIABLO, EIF2S1, EIF4B, EIF4E, EIF4EBP1, EIF4G1, IL21, IL1RN, INHA, INHBA, INHBB, JAK1, LEFTY1, MCL1, NFKB2, P4HA1, PPP1R15A (includes EG:23645), PRDM1, SATB1, SERPINB2, SOCS1, SOCS3, SUV39H1, TAL1, TLR4, TNF, TNFSF10, USF1, USF2        10E−3       18                Protein Synthesis, Cancer, Cell Death
                                                                                                                                                                                                                                                                                                                                            
  36   CEBPB, CSF1, CSF3, EGFR, FGA, GAB1, GRB2, IL6, IL1A, IL6ST, IRS1, JAK1, KIF5B, LIFR, LMO4, LPAR2, MAP2, MED28, NF2, NFKB1, OSM, OSMR, PIK3C2B, PLG, POU2F1, POU2F2, PRL, PTGS2, PTPN11, RNASE1, RNASE2, SKAP2, STAT3, TLR9, VIP                                                                        10E−3       18                Cellular Development, Cellular Growth and Proliferation, Cancer
                                                                                                                                                                                                                                                                                                                                            
  37   AOF2, BAZ1A, BAZ1B, CACNA1C, CDYL, CHRAC1, CTBP1, CTBP2, EHMT1, EHMT2, GATA4, HAND1, HAND2, HDAC2, HMG20B, KCNJ3, MEF2C, MYOCD, PDS5A, PHF21A, POLE3, RAD21, RBBP4, RCOR1, RREB1, SCN5A, SFRP1, SMARCA1, SMARCA5, SMC3, SMC1A, STAG1, STAG2, WIZ, ZEB2                                                 10E−3       18                Cell Cycle, DNA Replication, Recombination, and Repair, Gene Expression
                                                                                                                                                                                                                                                                                                                                            
  38   AKAP1, API5, ARHGEF12, CFTR, COL18A1, F2, F2R, FGF2, FGFR1, IL1B, IQGAP2, MPRIP, PPP1R12A, PRKAR2B, PRKG1, PTGER3, RHOA, SH3GLB1, SH3GLB2 (includes EG:56904), SLC9A3R1, SRC, STX1A, VCP                                                                                                               10E−3       13                Cellular Assembly and Organization, Cell Morphology, Cancer
                                                                                                                                                                                                                                                                                                                                            
  39   ACVR1, ACVR1B, ACVR2A, ANTXR1, APC, ASAP2, BCAP31, BIN1, BMP2, BMP6, BMP7, BMPR2, BMPR1A, CANX, COL18A1, CTNNB1, DCTN1, EFNB2, ERBB2, F10, ICAM1, ID1, ITGB2, MAPRE1, NOG, NRP1, PLP2, SEC23A, TGFB1, TLN1, TNFRSF21                                                                                   10E−3       16                Cell Signaling, Cellular Development, Connective Tissue Development and Function
                                                                                                                                                                                                                                                                                                                                            
  40   ARCN1, BRCA2, BRIP1, COPB1, COPG, CYLD, EXO1, HERC2, KPNA2, KPNB1, MAD2L2, MLH1, MMS19, MSH6, PIK3C2A, PMS1, PMS2, PSD2, PSMC1, RANBP9, REV1, REV3L, RFC2, RUFY1, SACM1L, SBF2, SSB (includes EG:6741), TMED9, UBA52, UBR5, USP5                                                                       10E−2       15                DNA Replication, Recombination, and Repair, Cancer, Gastrointestinal Disease
                                                                                                                                                                                                                                                                                                                                            
  41   CCNB1, CD44, EGFR, EIF3A, ERBB2, ERRFI1, GAB1, IL6ST, JARID1B, KRT7, MYBL2, MYO10, NEDD9, PARP1, PIK3CA, PIK3CD, PIK3R1, PIK3R2, RAB31, SMAD2, SOLH, SOX4, TGFB1, TGIF1, TGOLN2 (includes EG:10618), TNF                                                                                               10E−2       13                Cell Cycle, Cellular Growth and Proliferation, Carbohydrate Metabolism
                                                                                                                                                                                                                                                                                                                                            
  42   ADCYAP1, AMPD3 (includes EG:272), CCL3, CCL4, CCL5, CD40, CD40LG, CSF3, CXCL10, DUSP1, DUSP6, FURIN, IER2, IL3, IL17A (includes EG:3605), IL1B, ITGAM, MAP2K6, MAPK3, MAPK14, MMP9, NAMPT, NFKB2, NGF, NR4A2, NSMAF, P2RX7, PLD1, PLG, PTGFR, SERPINB2, TOB1, TRAF3, TSC22D3, VEGFA                    10E−2       16                Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking
                                                                                                                                                                                                                                                                                                                                            
  43   ATM, ATR (includes EG:545), C10ORF119, CDC6, CDC37, CDC25A, CDC25B, CHEK1, CHEK2, CSNK1A1, E2F1, FAS, GRB10, MAP3K11, MAP3K5 (includes EG:4217), MCM2, MCM3, MCM4, MCM7, MDM4, PLK1, PPP2R3A (includes EG:5523), PPP5C, RAD17, RAF1, SNAP23, SSH2, STX4, STX6, STX16, TP53, VAMP2, VAMP3, VIM, YWHAB   10E−2       16                DNA Replication, Recombination, and Repair, Cancer, Cell Cycle
                                                                                                                                                                                                                                                                                                                                            
  44   BAK1, BAX, BCL2, BCL2L1, BID, BMF, BSG, CAV1, CAV3, CDC2, CDK2, CIT, CYCS (includes EG:54205), DLG4, ECT2, GIT1, GRIN2A, HINT1, HTT, IGFBP5, KIF14, KIF23, KRAS, LRP1, MEOX2, NCL, NCSTN, NT5C3, PLK1, PRC1, PSEN1, PSEN2, RACGAP1, TP53, VDAC2                                                        10E−2       15                Cell Death, Cell Cycle, Cancer
                                                                                                                                                                                                                                                                                                                                            
  45   ASCL2, ASF1A, ATXN7, CCNH, CDK7, CRIP2, CSPG4, DKK1, ENO3, ERCC2, ERCC3, ESRRA, GK, GPR64, GTF2H1, GTF2H2, HMGN1, MLL2, MNAT1, NR2C2, NT5E, PPARGC1A, RBBP5, SAFB, SMAD6, TAF1, TAF2, TAF4, TAF8, TAF9, TAF11, TAF15, TFF1, TUBB, UTX                                                                  10E−2       15                Gene Expression, DNA Replication, Recombination, and Repair, Dermatological Diseases and Conditions
                                                                                                                                                                                                                                                                                                                                            
  46   ADAMTS5, BAX, BCL2, BCL2L1, BRCA1, CASP3, CCL3, CCL4, CD226, CD244, CSF2, FLNB, GP9, GP1BA, IL8, IL15, IL18, IL18R1, KLRK1, LCP2, MMP1 (includes EG:4312), MNT, MOAP1, NCR1, PDIA3, RAB9A, SELL, SOD2, TERT, TP63, VDAC1, XRCC6, YWHAE, YWHAQ (includes EG:10971), YWHAZ                               10E−2       15                Cell-to-Cell Signaling and Interaction, Hematological System Development and Function, Cell Death
                                                                                                                                                                                                                                                                                                                                            
  47   ABCA1, AKT1, APOA1, CCDC88A, CCL2, CCL5, COL2A1, CSH1, CUL5, FKBP1A, FLOT1, IGF1, IL8, IL13, IL1B, IL1RN, ILK, INS, LOX, MMP7, PDE4D, PDPK1, PGF, RNF4, RYR1 (includes EG:6261), SLC2A4, STK38L (includes EG:23012), TNF, TRPS1                                                                        10E−2       13                Cell-mediated Immune Response, Cellular Movement, Lipid Metabolism
                                                                                                                                                                                                                                                                                                                                            
  48   EIF2C1, EIF2C2, TNRC6A                                                                                                                                                                                                                                                                                 10E−2       3                 Infection Mechanism, Cancer, Respiratory Disease
                                                                                                                                                                                                                                                                                                                                            
  49   DMD, DTNA, DTNB                                                                                                                                                                                                                                                                                        10E−2       3                 Cellular Assembly and Organization, Nervous System Development and Function, Skeletal and Muscular System Development and Function

###### 

Molecules directly involved in endometriosis and networks in which they appear. IPA analysis indicated that several networks constituted by the predicted targets of the differentially expressed miRNAs include molecules known to be involved in endometriosis.

                                       Symbol                                                                                                           Entrez Gene Name                                                   Networks
  ------------------------------------ ---------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------ ----------
  Cytokines                            CD40LG                                                                                                           CD40 ligand                                                        38
  CX3CL1                               chemokine (C-X3-C motif) ligand 1                                                                                12                                                                 
  CXCL13                               chemokine (C-X-C motif) ligand 13                                                                                36                                                                 
  IL2                                  interleukin 2                                                                                                    2, 29, 37                                                          
  IL4                                  interleukin 4                                                                                                    29, 32, 37                                                         
  IL6                                  interleukin 6 (interferon, beta 2)                                                                               29                                                                 
  IL8                                  interleukin 8                                                                                                    28, 31                                                             
  IL18                                 interleukin 18 (interferon-gamma-inducing factor)                                                                29                                                                 
  SPP1                                 secreted phosphoprotein 1                                                                                        23, 46                                                             
  TNF                                  tumor necrosis factor (TNF superfamily, member 2)                                                                26, 29, 30, 33, 37, 38, 40, 41, 45                                 
                                                                                                                                                                                                                           
  Enzymes                              CNTN1                                                                                                            contactin 1                                                        23
  DNMT1                                DNA (cytosine-5-)-methyltransferase 1                                                                            5, 36                                                              
  DNMT3A                               DNA (cytosine-5-)-methyltransferase 3 alpha                                                                      5                                                                  
  DNMT3B                               DNA (cytosine-5-)-methyltransferase 3 beta                                                                       5                                                                  
  FN1                                  fibronectin 1                                                                                                    7, 28                                                              
  GNAS                                 GNAS complex locus                                                                                               41                                                                 
  GSTP1                                glutathione S-transferase pi 1                                                                                   49                                                                 
  HINT1                                histidine triad nucleotide binding protein 1                                                                     48                                                                 
  KRAS                                 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog                                                             3                                                                  
  PDE4A                                phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila)                             44                                                                 
  PDE4D                                phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila)                             41                                                                 
  PTGS2                                prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)                            7, 28                                                              
  RAC1                                 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)                          5                                                                  
  RAP1B                                RAP1B, member of RAS oncogene family                                                                             23                                                                 
  REV3L                                REV3-like, catalytic subunit of DNA polymerase zeta (yeast)                                                      39                                                                 
  RRM1 (includes EG:6240)              ribonucleotide reductase M1                                                                                      26                                                                 
  SAT1                                 spermidine/spermine N1-acetyltransferase 1                                                                       26                                                                 
  XRCC6                                X-ray repair complementing defective repair in Chinese hamster cells 6                                           42, 48                                                             
                                                                                                                                                                                                                           
  Growth Factors                       ANGPT2                                                                                                           angiopoietin 2                                                     7
  CTGF                                 connective tissue growth factor                                                                                  2, 36, 40                                                          
  FGF2                                 fibroblast growth factor 2 (basic)                                                                               23, 31                                                             
  INHBA                                inhibin, beta A                                                                                                  45                                                                 
  LEP                                  leptin                                                                                                           6                                                                  
  TGFB1                                transforming growth factor, beta 1                                                                               20, 26, 33, 35, 40, 45                                             
  VEGFA                                vascular endothelial growth factor A                                                                             29, 30                                                             
                                                                                                                                                                                                                           
  Ion Channels                         PKD1                                                                                                             polycystic kidney disease 1 (autosomal dominant)                   45
  PKD2 (includes EG:5311)              polycystic kidney disease 2 (autosomal dominant)                                                                 45                                                                 
                                                                                                                                                                                                                           
  Kinases                              CDC2                                                                                                             cell division cycle 2, G1 to S and G2 to M                         32, 36
  CSF1R                                colony stimulating factor 1 receptor                                                                             3, 34                                                              
  EGFR                                 epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)               28                                                                 
  ERBB2                                v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)   27, 30, 33, 35, 38, 40, 45, 47                                     
  FLT1                                 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)         2                                                                  
  INSR                                 insulin receptor                                                                                                 26                                                                 
  JAK1                                 Janus kinase 1 (a protein tyrosine kinase)                                                                       37                                                                 
  KIT                                  v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog                                                    9                                                                  
  MAPK4                                mitogen-activated protein kinase 4                                                                               17                                                                 
  NTRK2                                neurotrophic tyrosine kinase, receptor, type 2                                                                   45                                                                 
  PCK1                                 phosphoenolpyruvate carboxykinase 1 (soluble)                                                                    42                                                                 
  PDGFRA                               platelet-derived growth factor receptor, alpha polypeptide                                                       11                                                                 
  PDGFRB                               platelet-derived growth factor receptor, beta polypeptide                                                        11                                                                 
  PIK3R2                               phosphoinositide-3-kinase, regulatory subunit 2 (beta)                                                           17                                                                 
  SGK1                                 serum/glucocorticoid regulated kinase 1                                                                          16                                                                 
  STC1                                 stanniocalcin 1                                                                                                  49                                                                 
  WEE1                                 WEE1 homolog (S. pombe)                                                                                          18                                                                 
                                                                                                                                                                                                                           
  Ligand-Dependent Nuclear Receptors   AHR                                                                                                              aryl hydrocarbon receptor                                          44
  AR                                   androgen receptor                                                                                                30                                                                 
  ESR1                                 estrogen receptor 1                                                                                              5, 30, 44                                                          
  ESR2                                 estrogen receptor 2 (ER beta)                                                                                    44                                                                 
  PPARG                                peroxisome proliferator-activated receptor gamma                                                                 12, 29                                                             
                                                                                                                                                                                                                           
  Peptidases                           HPR (includes EG:3250)                                                                                           haptoglobin-related protein                                        24
  MEST                                 mesoderm specific transcript homolog (mouse)                                                                     18                                                                 
  MMP2                                 matrix metallopeptidase 2 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV collagenase)                          11                                                                 
                                                                                                                                                                                                                           
  Phosphatases                         DUSP1                                                                                                            dual specificity phosphatase 1                                     3
  PPP3R1                               protein phosphatase 3 (formerly 2B), regulatory subunit B, alpha isoform                                         24                                                                 
  PTEN                                 phosphatase and tensin homolog                                                                                   19                                                                 
  PTP4A1                               protein tyrosine phosphatase type IVA, member 1                                                                  22                                                                 
                                                                                                                                                                                                                           
  Transcription Regulators             BCL6                                                                                                             B-cell CLL/lymphoma 6                                              16
  BRCA1                                breast cancer 1, early onset                                                                                     5, 30, 42                                                          
  CITED2                               Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2                                11                                                                 
  CREB1                                cAMP responsive element binding protein 1                                                                        6                                                                  
  EGR1                                 early growth response 1                                                                                          6, 26, 35                                                          
  EMX2                                 empty spiracles homeobox 2                                                                                       15                                                                 
  FOS                                  v-fos FBJ murine osteosarcoma viral oncogene homolog                                                             6, 35, 49                                                          
  FOXO1                                forkhead box O1                                                                                                  3                                                                  
  GATA3                                GATA binding protein 3                                                                                           2                                                                  
  HIF1A                                hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)                          10, 31, 44, 47                                                     
  ID1                                  inhibitor of DNA binding 1, dominant negative helix-loop-helix protein                                           47, 50                                                             
  JUN                                  jun oncogene                                                                                                     49                                                                 
  JUNB                                 jun B proto-oncogene                                                                                             11, 47                                                             
  NRIP1                                nuclear receptor interacting protein 1                                                                           36                                                                 
  REL                                  v-rel reticuloendotheliosis viral oncogene homolog (avian)                                                       44                                                                 
  SMAD6                                SMAD family member 6                                                                                             14                                                                 
  SMAD7                                SMAD family member 7                                                                                             11                                                                 
  SP2                                  Sp2 transcription factor                                                                                         31                                                                 
  TP53                                 tumor protein p53                                                                                                22, 27, 32, 34, 36, 37, 40, 41, 45                                 
  WT1                                  Wilms tumor 1                                                                                                    7                                                                  
  ZFP36                                zinc finger protein 36, C3H type, homolog (mouse)                                                                20                                                                 
                                                                                                                                                                                                                           
  Transmembrane Receptors              IL2RG                                                                                                            interleukin 2 receptor, gamma (severe combined immunodeficiency)   37
  ITGB1                                integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)                     11, 28, 30                                                         
  ITGB3                                integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)                                                      7                                                                  
  ITGB4                                integrin, beta 4                                                                                                 30                                                                 
                                                                                                                                                                                                                           
  Transporters                         APOE                                                                                                             apolipoprotein E                                                   36
  ATP1B1                               ATPase, Na^+^/K^+^ transporting, beta 1 polypeptide                                                              41                                                                 
  ATP2B2                               ATPase, Ca^++^ transporting, plasma membrane 2                                                                   21                                                                 
  SLC6A6                               solute carrier family 6 (neurotransmitter transporter, taurine), member 6                                        1                                                                  
                                                                                                                                                                                                                           
  Others                               ACTB                                                                                                             actin, beta                                                        9, 49
  ANK3                                 ankyrin 3, node of Ranvier (ankyrin G)                                                                           24                                                                 
  BCL2                                 B-cell CLL/lymphoma 2                                                                                            3, 48                                                              
  BIRC5                                baculoviral IAP repeat-containing 5                                                                              36                                                                 
  BSG                                  basigin (Ok blood group)                                                                                         41                                                                 
  CAV2                                 caveolin 2                                                                                                       5                                                                  
  CCNA2                                cyclin A2                                                                                                        43                                                                 
  COL18A1                              collagen, type XVIII, alpha 1                                                                                    47                                                                 
  DCN                                  decorin                                                                                                          28                                                                 
  EPS15                                epidermal growth factor receptor pathway substrate 15                                                            28                                                                 
  ERRFI1                               ERBB receptor feedback inhibitor 1                                                                               45                                                                 
  EZR                                  ezrin                                                                                                            18                                                                 
  FBN1                                 fibrillin 1                                                                                                      36                                                                 
  IRS2                                 insulin receptor substrate 2                                                                                     6, 37                                                              
  ITGA6                                integrin, alpha 6                                                                                                30                                                                 
  LRP5                                 low density lipoprotein receptor-related protein 5                                                               6                                                                  
  MARCKS (includes EG:4082)            myristoylated alanine-rich protein kinase C substrate                                                            47                                                                 
  SDC2                                 syndecan 2                                                                                                       8                                                                  
  TAL1                                 T-cell acute lymphocytic leukemia 1                                                                              18                                                                 
  THBS2                                thrombospondin 2                                                                                                 11                                                                 
  TIMP2                                TIMP metallopeptidase inhibitor 2                                                                                11                                                                 
  TMSB10                               thymosin beta 10                                                                                                 19                                                                 
  TRAF2                                TNF receptor-associated factor 2                                                                                 26                                                                 
  VIM                                  vimentin                                                                                                         19, 36                                                             

###### 

Molecular networks constituted by the predicted miRNA targets. The list of differentially expressed miRNAs was directly uploaded in IPA and an analysis was performed in order to identify the molecular pathways and functions to which the predicted targets of the differentially expressed miRNAs belong. The database used by IPA to analyze miRNAs and their targets is Argonaute2 (<http://www.ma.uni-heidelberg.de/apps/zmf/argonaute/>). *P* \< .01.

  ID   Molecules in Network                                                                                                                                                                                                                                                                                                                                                                                                                                 *P*-value   Focus Molecules   Top Functions
  ---- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------- ----------------- --------------------------------------------------------------------------------
  1    AKAP3, ATP2A2, C11ORF87, CNKSR2, **CREB1**, CUGBP2, EIF4E3, ELK1, FLRT2, HOXB2, HOXD12, IFNG, KLHDC10, KPNB1, MIR25, MIR150, MIR186, MIR221, MIR299, MIR143 (includes EG:406935), MIR182 (includes EG:406958), MIR200A, MIR200B, MIR200C, MIR34A, MYST4, OTOF, PAQR3, PER1, RPGRIP1L, SNRPA, SRCAP, UBFD1, USP6NL, WDR44                                                                                                                             10E−24      11                Genetic Disorder, Skeletal and Muscular Disorders, Connective Tissue Disorders
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  2    **ATP1B1**, C4ORF16, CALU, DHX15, DIP2C, **DNMT3A**, **DNMT3B**, EVX2, FAM108C1, FBXL11, HOXA5, HOXA10, INO80, JPH3, KLHL18, MACF1, MAP2K6, MIR126, MIR100 (includes EG:406892), MIR130A (includes EG:406919), MIR130B (includes EG:406920), MIR132 (includes EG:406921), MIR148A (includes EG:406940), MIR20A, MIR29B, MIR29B1, MIR29B2, MIR29C, **MPPED2** (includes EG:744), NUFIP2, SMARCE1, SOX6, ZFP36L2, ZNF238, ZNF318 (includes EG:24149)   10E--19     9                 Genetic Disorder, Skeletal and Muscular Disorders, Infection Mechanism
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  3    ADIPOR2, **AR**, ARF4, CAND1, CCNT2, CDKN1A, CHSY1, FBXW7, FNDC3B, IRS1, **JUN**, KLF6, LASS2, MAP1D, MDM2, MIR93, MIR375, MIR1 (human), MIR106A (includes EG:406899), MIR106B (includes EG:406900), MIR145 (includes EG:406937), MIR183 (includes EG:406959), MIR196B, MIR99A, MTPN, NPAT, NPPC, PDCD4, PFTK1, PPM1D, SERP1, SERPINB5, SLC16A2, TDG, TRIM2                                                                                          10E−18      9                 Cancer, Reproductive System Disease, Cell Cycle
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  4    MIR376A, MIR376A1, MIR376A2                                                                                                                                                                                                                                                                                                                                                                                                                          10E−2       1                 Genetic Disorder, Skeletal and Muscular Disorders
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  5    MIR365, MIR365-1, MIR365-2                                                                                                                                                                                                                                                                                                                                                                                                                           10E−2       1                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  6    EZH2, MIR101, MIR101-1, MIR101-2, MYCN                                                                                                                                                                                                                                                                                                                                                                                                               10E−2       1                 Cancer, Cellular Movement, Reproductive System Disease

###### 

Gene Ontology analysis of the predicted target genes of 50 miRNAs differentially expressed. Onto-Express analysis on predicted targets of the differentially expressed miRNAs identified enrichment for biological process categories. The *gene* column indicates the number of predicted targets of the differentially expressed miRNAs upon the number of the targets of all miRNAs considered for the study. Significant differences from the number of targets in each GO category with the expected number of genes were calculated with the assumption of a hypergeometric distribution and *P*-values were adjusted with the false discovery rate (fdr) correction. *P* \< .05.

  Rank   Biological process category                                  Genes       Corrected *P*-value
  ------ ------------------------------------------------------------ ----------- ---------------------
  1      Cellular process                                             2408/6644   .0
          Cell motion                                                 148/330     .0
          Cell communication                                          908/2223    .0
          Cellular component organization                             546/1383    .0
          Cellular developmental process                              400/949     .0
          Cellular metabolic process                                  1563/4269   .0
          Regulation of cellular process                              1555/3840   .0
          Cell development                                            183/419     .0
          Positive regulation of cellular process                     371/875     .0
          Negative regulation of cellular process                     394/932     .0
          Cell cycle                                                  223/555     1.0E−5
          Cell death                                                  235/587     2.0E−5
          Cell proliferation                                          237/602     5.0E−5
          Actin-filament based process                                90/197      6.0E−5
          Cell fate commitment                                        45/83       9.0E−5
          Cell aging                                                  14/21       7.0E−4
          Vescicle-mediated transport                                 158/397     7.3E−4
          Cell growth                                                 51/112      .00286
          Cell fate determination                                     15/23       .00286
          Cellular localization                                       224/609     .00506
          Gene silencing                                              16/27       .00696
          Cell cycle process                                          124/323     .00696
          Translational initiation                                    23/48       .01253
          Cell fate specification                                     12/20       .01728
          Cellular response to stimulus                               110/292     .03290
          Cell adhesion                                               173/479     .04094
                                                                                  
  2      Negative regulation of biological process                    421/992     .0
          Negative regulation of metabolic process                    193/422     .0
          Negative regulation to cellular process                     394/932     .0
          Negative regulation of developmental process                129/309     1.9E−4
          Negative regulation of response to stimulus                 16/29       .01705
          Negative regulation of growth                               24/53       .03564
                                                                                  
  3      Multicellular organismal process                             820/2037    .0
          Multicellular organismal development                        675/1606    .0
          Regulation of multicellular organismal process              171/421     2.0E−4
          System process                                              227/606     .00750
          Respiratory gaseous exchange                                11/17       .01639
                                                                                  
  4      Biological regulation                                        1656/4148   .0
          Regulation of molecular function                            211/478     .0
          Regulation of biological process                            1597/3961   .0
          Regulation of biological quality                            281/732     1.3E−4
                                                                                  
  5      Regulation of biological process                             1597/3961   .0
          Regulation of metabolic process                             850/2038    .0
          Regulation of developmental process                         283/657     .0
          Regulation of cellular process                              1555/3840   .0
          Positive regulation of cellular process                     384/933     .0
          Negative regulation of cellular process                     421/992     .0
          Regulation of multicellular organismal process              171/421     1.4E−4
          Regulation of localization                                  110/261     8.7E−4
          Regulation of locomotion                                    41/95       .02619
          Regulation of growth                                        64/164      .04199
                                                                                  
  6      Metabolic process                                            1631/4509   .0
          Biosynthetic process                                        899/2354    .0
          Negative regulation of metabolic process                    193/422     .0
          Positive regulation of metabolic process                    201/473     .0
          Regulation of metabolic process                             1563/2038   .0
          Cellular metabolic process                                  1563/4269   .0
          Primary metabolic process                                   1551/4187   .0
          Macromolecule metabolic process                             1383/3644   .0
          Oxydation reduction                                         52/255      5.0E−5
          Catabolic process                                           237/665     .01317
          Nitrogen compound metabolic process                         49/193      .03270
                                                                                  
  7      Developmental process                                        821/1967    .0
          Multicellular organismal development                        675/1606    .0
          Anatomical structure morphogenesis                          310/710     .0
          Embryonic development                                       140/304     .0
          Anatomical structure development                            584/1379    .0
          Cellular developmental process                              400/949     .0
          Regulation of developmental process                         283/657     .0
          Positive regulation of developmental process                131/295     1.0E−5
          Anatomical structure formation involved in Morphogenesis    97/216      4.0E−5
          Pattern specification process                               79/173      1.6E−4
          Negative regulation of developmental process                129/309     1.6E−4
          Pigmentation during development                             9/13        .01264
          Reproductive developmental process                          31/68       .02708
          Aging                                                       17/36       .04082
                                                                                  
  8      Positive regulation of biological process                    384/933     .0
          Positive regulation of metabolic process                    201/473     .0
          Positive regulation of cellular process                     371/875     .0
          Positive regulation of developmental process                131/295     1.0E−5
          Positive regulation of homeostatic process                  6/8         .03203
                                                                                  
  9      Localization                                                 715/1953    .0
          Localization of cell                                        148/330     .0
          Macromolecule localization                                  247/638     1.1E−4
          Regulation of localization                                  110/261     7.7E−4
          Cellular localization                                       224/609     .00422
          Establishment of localization                               577/1657    .00463
                                                                                  
  10     Death                                                        235/591     2.0E−5
          Cell death                                                  235/587     1.0E−5
                                                                                  
  11     Anatomical structure formation                               242/629     1.1E−4
          Anatomical structure formation involved in  Morphogenesis   97/216      3.0E−5
          Cellular component assembly                                 165/452     .01276
                                                                                  
  12     Response to stimulus                                         464/1276    2.4E−4
          Response to chemical stimulus                               185/465     5.3E−4
          Response to endogenous stimulus                             59/136      .00633
          Negative regulation to response to stimulus                 16/29       .01844
          Behavior                                                    84/215      .02638
          Cellular response to stimulus                               110/292     .03534
          Response to stress                                          253/718     .03918
                                                                                  
  13     Multi-organism process                                       113/286     .00251
          Interspecies interaction between organisms                  71/172      .00565
          Female pregnancy                                            19/39       .04504
                                                                                  
  14     Growth                                                       96/235      .00334
          Cell growth                                                 51/112      .00298
          Negative regulation of growth                               24/53       .03391
          Regulation of growth                                        64/164      .03916
                                                                                  
  15     Locomotion                                                   111/277     .00422
          Cell motility                                               97/223      3.5E−4
          Regulation of locomotion                                    41/95       .02439
                                                                                  
  16     Establishment of localization                                577/1657    .00458
          Establishment of protein localization                       207/536     3.3E−4
          Establishment of localization in cell                       209/576     .01045
                                                                                  
  17     Reproduction                                                 117/303     .00983
          Reproductive process                                        116/301     .01127
                                                                                  
  18     Reproductive process                                         116/301     .01024
          Reproductive developmental process                          31/68       .03090
          Female pregnancy                                            19/39       .04504
                                                                                  
  19     Biological adhesion                                          173/479     .03486
          Cell adhesion                                               173/479     .03486
                                                                                  
  20     Rhythmic process                                             26/59       .04158

###### 

KEGG pathways containing the predicted targets of the differentially expressed miRNAs. Pathway-Express analysis identified the KEGG molecular pathways affected by the predicted targets of the differentially expressed miRNAs. *P* \< .05.

  Rank   Pathway name                            Genes in pathway   Input genes in pathway   Pathway genes on chip   *P*-value
  ------ --------------------------------------- ------------------ ------------------------ ----------------------- -----------
  1      MAPK signaling pathway                  272                103                      197                     3.23E−08
  2      Axon guidance                           129                67                       113                     3.23E−08
  3      Melanogenesis                           102                48                       74                      8.60E−08
  4      Pathways in cancer                      330                119                      245                     2.27E−07
  5      Regulation of actin cytoskeleton        217                78                       158                     2.31E−05
  6      Focal adhesion                          203                75                       150                     2.31E−05
  7      Wnt signaling pathway                   152                63                       127                     1.60E−04
  8      Glioma                                  65                 30                       50                      2.94E−04
  9      GnRH signaling pathway                  103                36                       65                      4.86E−04
  10     Renal cell carcinoma                    69                 34                       61                      5.92E−04
  11     Insulin signaling pathway               138                49                       98                      7.02E−04
  12     Adherens junction                       78                 34                       62                      7.65E−04
  13     TGF-beta signaling pathway              87                 38                       72                      8.49E−04
  14     Prostate cancer                         90                 36                       68                      .0011
  15     ECM-receptor interaction                84                 30                       55                      .0016
  16     Phosphatidylinositol signaling system   76                 30                       55                      .0016
  17     Calcium signaling pathway               182                54                       115                     .0016
  18     Colorectal cancer                       84                 36                       70                      .0018
  19     Long-term potentiation                  73                 31                       58                      .0018
  20     Adipocytokine signaling pathway         67                 27                       50                      .0032
  21     ErbB signaling pathway                  87                 34                       69                      .0056
  22     Pancreatic cancer                       72                 30                       59                      .0056
  23     Gap junction                            96                 33                       67                      .0063
  24     Type II diabetes mellitus               45                 18                       31                      .0069
  25     Small cell lung cancer                  86                 30                       61                      .0095
  26     Thyroid cancer                          29                 14                       23                      .0111
  27     Ubiquitin mediated proteolysis          138                42                       94                      .0145
  28     Long-term depression                    75                 24                       49                      .0225
  29     Non-small cell lung cancer              54                 20                       39                      .0225
  30     Acute myeloid leukemia                  59                 22                       45                      .0304
  31     Melanoma                                71                 25                       53                      .0323
  32     Cardiac muscle contraction              87                 20                       41                      .0402
  33     Chronic myeloid leukemia                75                 28                       62                      .0410

###### 

Genes aberrantly expressed in ovarian and peritoneal endometriosis that are predicted targets of the differentially expressed miRNAs. The miRNAs predicted to regulate the expression of the genes known to be aberrantly up- (↑) or downregulated (↓) in both ovarian and peritoneal endometriosis were identified by TARGETSCAN and PICTAR algorithms. MicroRNAs whose regulation is in accordance with the resulting expression of their predicted target genes are reported in bold.

  Target genes                                                                                    microRNAs upregulated          microRNAs downregulated
  ----------------------------------------------------------------------------------------------- ------------------------------ -----------------------------------------------------------------------
  CA3 (carbonic anhydrase III) ↑                                                                  hsa-miR-29b; hsa-miR-29c       
  CAV1 (caveolin 1) ↑                                                                             hsa-miR-199a; hsa-miR-30e-3p   **hsa-miR-20a; hsa-miR-106b**
  CAV2 (caveolin 2) ↑                                                                             hsa-miR-29b; hsa-miR-29c       
  DMD (dystrophin) ↑                                                                              hsa-miR-101; hsa-miR-30e-5p    **hsa-miR-200b; hsa-miR-200c**
  EPHA3 (EPH receptor A3) ↑                                                                       hsa-miR-29b; hsa-miR-29c       **hsa-miR-182**
  FZD7 ↑ (frizzled homolog 7)                                                                     hsa-miR-145; hsa-miR-1         **hsa-miR-20a; hsa-miR-106b**
  GALNT3 (UDP-N-acetyl-alpha-D-galactosamine) ↓                                                   **hsa-miR-30e-5p**             
  KCNMA1 (potassium large conductance calcium-activated channel, subfamily M, alpha mamber 1) ↑   hsa-miR-186                    **hsa-miR-93; hsa-miR-17-5p; hsa-miR-20a; hsa-miR-106b**
  LMO3 (LIM domain only 3) ↑                                                                                                     **hsa-miR-20a; hsa-miR-93; hsa-miR-17-5p; hsa-miR-183; hsa-miR-106b**
  NFASC (neurofascin) ↑                                                                           hsa-miR-150                    **hsa-miR-200b; hsa-miR-200c; hsa-miR-182**
  PDE4DIP (phosphodiesterase 4D interacting protein) ↑                                                                           **hsa-miR-183**
  PLS1 (plastin 1) ↓                                                                              **hsa-miR-30e-5p**             hsa-miR-17-5p; hsa-miR-20a; hsa-miR-106b
  PTPN3 (protein tyrosine phosphatase, non-receptor type 3) ↓                                                                    hsa-miR-17-5p; hsa-miR-20a; hsa-miR-106b
  RGS2 (regulator of G-protein signalling 2) ↑                                                    hsa-miR-30e-5p                 **hsa-miR-182**
  RGS5 (regulator of G-protein signalling 5) ↑                                                    hsa-miR-186                    
  RPS6KA5 (ribosomal protein S6 kinase, 90 kDa, polypeptide 5) ↓                                  **hsa-miR-148a**               hsa-miR-93; hsa-miR-17-5p; hsa-miR-20a; hsa-miR-106b
  SCAP2 (src family associated phosphoprotein 2) ↑                                                                               **hsa-miR-182**
  SLCO3A1 (solute carrier organic anion transporter family, member 3A1) ↑                         hsa-miR-34a                    **hsa-miR-182**
  SNAP25 (synaptosomal-associated protein) ↑                                                      hsa-miR-130a; hsa-miR-1        **hsa-miR-130b; hsa-miR-200b; hsa-miR-200c**
  TNFSF12 (tumor necrosis factor superfamily, member 12) ↑                                        hsa-miR-28                     

###### 

Molecular networks constituted by the common differentially expressed transcripts in ovarian and peritoneal endometriosis predicted to be targets of the 50 miRNAs. Differentially expressed genes common to both ovarian and peritoneal endometriosis that are predicted targets of the 50 differentially expressed miRNAs were uploaded in IPA in order to identify the molecular networks and functions to which they belong. *P* \< .01.

  ID   Molecules in Network                                                                      *P*-value   Focus Molecules   Top Functions
  ---- ----------------------------------------------------------------------------------------- ----------- ----------------- ------------------------------------------------------------------------------------------------------------------------------------
  1    CAV1, CAV2, CDKN1A, ESR1, HMGA1, LPL, MMP2, NOS3, SMARCA4, SP1, SP3, SRC, TNFSF12, TP53   10E−8       4                 Cancer, Cell Cycle, Reproductive System Disease
                                                                                                                               
  2    MBD1, SLCO3A1                                                                             10E−2       1                 Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry
                                                                                                                               
  3    RGS2, TNF                                                                                 10E−2       1                 Lipid Metabolism, Small Molecule Biochemistry, Cell Signaling
                                                                                                                               
  4    DMD, DTNA, DTNB                                                                           10E−2       1                 Cellular Assembly and Organization, Nervous System Development and Function, Skeletal and Muscular System Development and Function
                                                                                                                               
  5    FYB, GRB2, SKAP2                                                                          10E−2       1                 Cell-To-Cell Signaling and Interaction, Cell-mediated Immune Response, Cellular Growth and Proliferation
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